A1,
A2,
B,
C1,
C2,
D,
E,
F,
G-H,
I-K,
L,
M,
N,
O,
P1,
P2,
Q-R,
S,
T,
U-V,
W-Z
Tenuate Indications, Dosage, Storage, Stability - Diethylpropion
Tenuate Indications, Dosage, Storage, Stability - Diethylpropion
INDICATIONS
TENUATE and TENUATE DOSPAN are indicated in the management of exogenous
obesity as a short-term adjunct
(a few weeks) in a regimen
of weight reduction based
on caloric restriction.
The usefulness of agents of this class
(see CLINICAL PHARMACOLOGY)
should be measured against possible risk
factors inherent in
their use such as those
described below.
DOSAGE AND ADMINISTRATION
TENUATE (diethylpropion hydrochloride) immediate-release:
One immediate-release 25 mg
tablet three times daily,
one hour before meals, and in midevening if desired to overcome
night hunger.
TENUATE DOSPAN (diethylpropion hydrochloride) controlledrelease:
One controlled-release 75 mg
tablet daily, swallowed
whole, in midmorning.
HOW SUPPLIED
25 mg immediate-release
tablets in bottles of 100
Each white, round tablet
is debossed TENUATE 25 or MERRELL 697
Keep tightly closed, store at room
temperature, preferably below 86° F. Protect from excessive
heat.
75 mg controlled-release
tablets in bottles of 100
75 mg controlled-release
tablets in bottles of 250
Each white, capsule-shaped tablet
is debossed TENUATE 75 or MERRELL 698 Keep tightly closed. Store
at room temperature, below
86° F.
top
